Compile Data Set for Download or QSAR
Report error Found 101 of affinity data for UniProtKB/TrEMBL: P03367
TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM128418(US8802724, 23c | US8802724, 23a)
Affinity DataKi:  0.00290nMAssay Description:The enzyme inhibitory activity (Ki) was determined according to an assay protocol reported by Toth and Marshall (Toth, M. V.; Marshall, G. R. Int. J....More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM128417(US8802724, 3a)
Affinity DataKi:  0.0140nMAssay Description:The enzyme inhibitory activity (Ki) was determined according to an assay protocol reported by Toth and Marshall (Toth, M. V.; Marshall, G. R. Int. J....More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM128418(US8802724, 23c | US8802724, 23a)
Affinity DataKi:  0.0350nMAssay Description:The enzyme inhibitory activity (Ki) was determined according to an assay protocol reported by Toth and Marshall (Toth, M. V.; Marshall, G. R. Int. J....More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM128419(US8802724, 23d | US8802724, 23b)
Affinity DataKi:  0.0730nMAssay Description:The enzyme inhibitory activity (Ki) was determined according to an assay protocol reported by Toth and Marshall (Toth, M. V.; Marshall, G. R. Int. J....More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM128419(US8802724, 23d | US8802724, 23b)
Affinity DataKi:  0.300nMAssay Description:The enzyme inhibitory activity (Ki) was determined according to an assay protocol reported by Toth and Marshall (Toth, M. V.; Marshall, G. R. Int. J....More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434878(US10583140, Example 1 | ((1aR,2S,5R,5aS,6S,8aS,9R,...)
Affinity DataEC50:  7nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434941(US10583140, Example 2 | ((1aR,2S,5R,5aS,6S,8aS,9R,...)
Affinity DataEC50:  22nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126682(US8785638, 170)
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126676(US8785638, 161)
Affinity DataIC50: 55.4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM98672(US8497270, 35)
Affinity DataIC50: 200nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM98668(US8497270, 29)
Affinity DataIC50: 250nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434950(US10583140, Example 10 | ((1aR,2S,5R,5aR,6S,8aS,9R...)
Affinity DataEC50:  278nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM98669(US8497270, 30)
Affinity DataIC50: 360nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126692(US8785638, 190)
Affinity DataIC50: 370nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126690(US8785638, 186)
Affinity DataIC50: 430nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434945(US10583140, Example 5 | ((1aR,2S,5R,5aR,6S,8aS,9R,...)
Affinity DataEC50:  616nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126634(US8785638, 116)
Affinity DataIC50: 620nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126631(US8785638, 142 | US8785638, 113)
Affinity DataIC50: 750nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126635(US8785638, 117)
Affinity DataIC50: 780nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM98665(US8497270, 24)
Affinity DataIC50: 950nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126632(US8785638, 114)
Affinity DataIC50: 1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126679(US8785638, 165)
Affinity DataIC50: 1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126685(US8785638, 175)
Affinity DataIC50: 1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM98667(US8497270, 28)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434947(US10583140, Example 7 | ((1aR,2S,5R,5aR,6S,8aS,9R,...)
Affinity DataEC50:  1.05E+3nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434942(US10583140, Example 3 | (1aR,2S,5R,5aS,6S,8aS,9R,1...)
Affinity DataEC50:  1.11E+3nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126630(US8785638, 112)
Affinity DataIC50: 1.11E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM98670(US8497270, 31)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126683(US8785638, 171)
Affinity DataIC50: 1.21E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126666(US8785638, 150)
Affinity DataIC50: 1.37E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126677(US8785638, 162)
Affinity DataIC50: 1.57E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM98671(US8497270, 32)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2013
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126664(US8785638, 148)
Affinity DataIC50: 2.19E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM97447(Aspartyl protease inhibitor, 13)
Affinity DataIC50: 2.20E+3nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2013
Entry Details Article
PubMed
TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126637(US8785638, 119)
Affinity DataIC50: 2.66E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126638(US8785638, 120)
Affinity DataIC50: 2.72E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126643(US8785638, 127)
Affinity DataIC50: 2.85E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126680(US8785638, 166)
Affinity DataIC50: 3.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126639(US8785638, 122)
Affinity DataIC50: 3.20E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM97448(Aspartyl protease inhibitor, 14)
Affinity DataIC50: 3.30E+3nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2013
Entry Details Article
PubMed
TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126689(US8785638, 184)
Affinity DataIC50: 3.44E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434951(US10583140, Example 11 | (1aR,2S,5R,5aS,6S,8aS,9R,...)
Affinity DataEC50:  3.50E+3nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434946(US10583140, Example 6 | ((1aR,2S,5R,5aR,6S,8aS,9R,...)
Affinity DataEC50:  3.68E+3nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126629(US8785638, 110)
Affinity DataIC50: 4.31E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM434948(US10583140, Example 8 | ((1aR,2S,5R,5aR,6S,8aS,9R,...)
Affinity DataEC50:  4.33E+3nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details Article
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126652(US8785638, 136)
Affinity DataIC50: 4.34E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126627(US8785638, 108)
Affinity DataIC50: 4.48E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126678(US8785638, 163)
Affinity DataIC50: 4.50E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126647(US8785638, 131)
Affinity DataIC50: 4.54E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Purdue Research Foundation

US Patent
LigandPNGBDBM126662(US8785638, 146)
Affinity DataIC50: 4.76E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2014
Entry Details
US Patent

Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: